Endometrial Cancer Risk Factors
Research results from Fred Hutchinson Cancer Research Center, Division of Public Health Sciences update understanding of endometrial cancer risk factors
Published in Women's Health Weekly, October 4th, 2007
New investigation results, "Endometrial cancer risk in estrogen users after switching to estrogen-progestin therapy," are detailed in a study published in Cancer Causes and Control. According to recent research from the United States, "It is unknown whether postmenopausal unopposed estrogen users are better off, in terms of endometrial cancer risk, switching to a combined estrogen-progestin regimen or stopping hormone use altogether. We analyzed data from a series of three population-based case-control studies in western Washington state during 1985-1999, comparing proportions of "switchers" and "stoppers" in cases and controls."
"We also assessed whether the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
Linchpin gene may be useful target for new breast cancer therapies - Cervical Cancer
Bright tumors, dim prospects - Community Health
American College of Physicians publishes 'The Fenway Guide to LGBT Health' - HIV/AIDS
Different HIV rates among gay men and straight people not fully explained by sexual behavior - HIV/AIDS
Pregnancy May Help Cut Risks for HIV-infected Women - Menopause
Cholesterol byproduct blocks heart health benefits of estrogen - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
